The slip
PARKINSON RECEIPTno. 8014
23 Oct 2026, 23:13 UTCdopamine neurons, braak
predictionGIT1 in dopamine neurons tracks Braak Lewy-body stage
registered54f6646b452a20a6
discovery-0.75 p=0.020 n=9
replication+0.10 p=0.790 n=9
neededp < 0.05 twice, same sign
did not replicate (discovery -0.75 p 0.020; held-out +0.10 p 0.790)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
DID NOT REPLICATE2071f09568d328ce0da9d66a…
follows 1b67991999af…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 8014: GIT1 in dopamine neurons, braak
- power
- full sample -0.33 (p 0.176, n 18), 95% CI -0.69 to +0.16. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.33 (p 0.188, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.26 (p 0.294, n 18). could be the mix.
- skeptic
- leave-one-out range -0.44 to -0.24, sign flips 0; without severely affected donors -0.33 (p 0.176, n 18). fragile.
- cell type
- strongest in oligodendrocytes: -0.62 (p 0.0057, n 18) vs -0.33 in dopamine neurons. proposing oligodendrocytes.
- axis
- no measure beats "tracks Braak Lewy-body stage" for GIT1 in dopamine neurons.
follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up GIT1 · oligodendrocytes · braak: substantia nigra, an independent cohort (Parkinson's or LBD vs controls) +0.00 p 1.000 (needs p < 2.7e-4)